Loading…
Loading…
Tender Value
₹4.9 Cr
EMD Value
₹9.7 L
Closing Date
4 Aug 2026, 6:30 pm
Executive Director
AIIMS Mangalagiri Guntur 522503
Supply of Critical Drugs III to AIIMS Mangalagiri on Rate Contract basis for a period of 2 years
2026_AIMSM_917390_1
AIIMSMG/26-27/ RC/Critical Drugs III
Open Tender
Drugs and Pharmaceutical Products
Supply
AIIMS Mangalagiri
Please refer Tender documents.
3 documents required · 3 mandatory
₹0
₹9.7 L
Yes
Conference Hall, MS Office, IPD Block, AIIMS MG
14 Jul 2026
14 Jul 2026
5 Aug 2026
14 Jul 2026
4 Aug 2026
14 Jul 2026
14 Jul 2026 - 24 Jul 2026
22 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Item Description with specifications | |||||
| 1.01 | Tacrolimus 2 mg Capsule | 1 | 30 ug Disc Content As per CLSI | - | - |
| 2.01 | Tacrolimus 1 mg Capsule | 1 | 30 ug Disc Content As per CLSI | - | - |
| 3.01 | Everolimus 0.5 mg Tablet | 1 | 10/10 ug Disc Content As per CLSI | - | - |
| 4.01 | Ropivacaine 0.2% Injection (20 ml) | 1 | 30 ug Disc Content As per CLSI | - | - |
| 5.01 | Bupivacaine 0.5% Injection (20 ml) | 1 | 20/10 ug Disc Content As per CLSI | - | - |
| 6.01 | Ketorolac Tromethamine 30 mg/ml Injection | 1 | 15 ug Disc Content As per CLSI | - | - |
| 7.01 | Neostigmine + Glycopyrrolate Injection | 1 | 30 ug Disc Content As per CLSI | - | - |
| 8.01 | Ticagrelor 90 mg Tablet | 1 | 30 ug Disc Content As per CLSI | - | - |
| 9.01 | Adenosine 6 mg/2 ml Injection | 1 | 30 ug Disc Content As per CLSI | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 1.31 MB
TenDoc.pdf
Tender Documents • 0.74 MB
BOQ_964078.xls
BOQ • 0.36 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].